OSA is characterised by repetitive collapse of the upper airway during sleep. The soft palate, tongue and pharyngeal walls fall together → complete (apnoea) or partial (hypopnoea) obstruction → oxygen desaturation → arousal → airway reopens → cycle repeats.
Result: Fragmented, non-restorative sleep → daytime somnolence, cognitive impairment, cardiovascular stress from repeated nocturnal hypoxia and sympathetic surges.
CSA involves absent respiratory drive — the airway is patent but no effort is made to breathe. Distinct from OSA where effort continues against a blocked airway.
Cheyne-Stokes respiration — oscillating ventilation driven by unstable loop gain. Associated with reduced LVEF.
Opioids suppress medullary respiratory centres — dose-dependent central apnoeas, especially at sleep onset and REM.
Brainstem lesions (stroke, tumour), Arnold-Chiari malformation, motor neurone disease impair respiratory pacemaker.
CSA can emerge after CPAP initiation for OSA (complex sleep apnoea) — BiPAP-ST or ASV may be needed.
The AHI counts the number of apnoeas + hypopnoeas per hour of sleep. It is the primary severity metric for OSA but does not capture oxygen desaturation burden or arousals alone.
| Severity | AHI (events/hour) | Oxygen Desaturation Index | Clinical Impact | Typical Management |
|---|---|---|---|---|
| Mild | 5–15/h | ODI 5–15 | Daytime sleepiness, impaired concentration, snoring | Sleep hygiene, positional therapy, weight loss; CPAP if symptomatic |
| Moderate | 15–30/h | ODI 15–30 | Significant daytime impairment, mood disturbance, HTN risk | CPAP or APAP — standard of care |
| Severe | >30/h | ODI >30 | Profound somnolence, cardiovascular risk, metabolic syndrome, AF | CPAP/APAP urgent; consider BiPAP if co-existing OHS/COPD |
Diagnostic criteria: BMI >30 kg/m² + awake daytime PaCO₂ >6 kPa (45 mmHg) + no other cause for hypoventilation.
OHS requires BiPAP, not CPAP alone. Elevated PaCO₂ indicates chronic ventilatory failure — CPAP does not provide inspiratory pressure support needed to reduce CO₂.
The GCC region faces an extremely high and growing OSA burden driven by multiple converging risk factors:
Sleep study capacity in GCC is expanding rapidly — DHA, DOH, MOH Saudi Arabia all have published OSA guidelines. Bariatric programmes in UAE and KSA mandatorily screen for OSA pre-operatively.
Full overnight in-lab study. Nursing setup involves applying and monitoring multiple channels:
Most common in GCC outpatient practice. Simplified device — typically 3–4 channels: airflow, SpO₂, respiratory effort, position. Note: AHI from HSAT is calculated on total recording time (not sleep time) — tends to underestimate true AHI. Suitable for moderate-high probability OSA without comorbidities.
HSAT limitations: Cannot diagnose CSA, OHS hypoventilation, or accurately assess severe insomnia. PSG needed for complex cases.
A validated pre-screening tool for OSA risk. Each letter represents one criterion — score 0–8. Score ≥5 = high risk.
Small silicone inserts into nostrils. Least claustrophobic, good for active sleepers. Fails in mouth-breathers — air escapes through mouth. Best tolerated at lower pressures.
Covers nose only. Most commonly prescribed — good seal, range of styles. Chin strap can be added for mouth breathing. Preferred starting point for new CPAP users.
Covers nose and mouth. Necessary for mouth-breathers who fail nasal mask. Used in hospital NIV. Higher leak risk. Some patients feel claustrophobic — less preferred long-term.
Nurse tip: Always trial mask fit while patient is awake and sitting up before their first night. Proper fit = no visible air leak around seal, no excessive pressure on skin, patient can breathe comfortably through device.
Absolute contraindications — intubate instead:
Relative: Haemodynamic instability, inability to cooperate, severe agitation — assess risk/benefit with senior.
ABG response targets: pH rising towards 7.35+, PaCO₂ falling, RR decreasing. If pH <7.25 or worsening after 1–4h — senior review + ITU/anaesthetics.
The bridge of the nose is the most common NIV pressure injury site — thin skin, bony prominence, constant strap pressure.
Claustrophobia and panic are common barriers to NIV — can cause NIV failure independent of clinical condition.
Call senior + ITU/anaesthetics immediately. Prepare for intubation. Do not delay — NIV failure with delayed intubation has very poor outcome.
Adherence is monitored via the CPAP device data chip/card (SD card or wireless cloud upload). Review at clinic shows: usage hours per night, AHI on therapy, mask leak levels, events (residual apnoeas). Non-adherence triggers clinical review and troubleshooting.
Long-term benefits of adherent CPAP use: Blood pressure reduction (strongest in severe OSA with HTN), reduced AF recurrence, improved daytime alertness, improved quality of life, reduced road traffic accident risk.
| Problem | Likely Cause | Nursing/Clinical Intervention |
|---|---|---|
| Mask Leak | Poor fit, wrong mask size, facial hair, mouth breathing | Re-fit mask; try different style or size; add chinstrap for mouth breathing; consider full-face mask |
| Aerophagia / Bloating | Air swallowing — pressure too high, mouth-breathing with full-face mask | Reduce CPAP pressure (or narrow APAP range); add chinstrap; consider APAP to lower mean pressure; rarely, positional wedge |
| Claustrophobia | Anxiety, panic response to mask confinement | Gradual acclimatisation — wear mask while awake watching TV; try nasal pillow (least intrusive); cognitive behavioural support |
| Dry Mouth / Throat | Mouth breathing, inadequate humidification | Add or increase heated humidifier temperature; switch to full-face mask; ensure chinstrap for nasal mask users |
| Pressure Intolerance | High fixed pressure uncomfortable, especially on exhalation | Switch to APAP; enable EPR (Expiratory Pressure Relief) or C-Flex comfort setting; ramp feature — pressure rises gradually as patient falls asleep |
| Residual Sleepiness | Inadequate AHI control, subtherapeutic pressure, co-existing CSA or narcolepsy | Review device data — check AHI on therapy, leak levels; consider PSG review; exclude other sleep disorders; assess medication side effects |
Do not use: bleach, alcohol, or dishwasher — degrade silicone and polycarbonate. Use only CPAP-approved cleaning agents or mild unscented soap.
Common patient concern — many question whether CPAP use breaks the fast. Fatwa from Islamic scholars: CPAP does not constitute eating or drinking — it is permissible during fasting. CPAP should be used on all sleeping occasions including daytime Ramadan sleep.
Address sensitively — mask appearance and machine noise can affect intimate relationships. Key points:
Despite the hot, humid GCC environment, air-conditioned bedrooms are very dry. Heated humidifier significantly improves comfort and adherence — recommend as standard in GCC patients.
All surgical patients should be screened for OSA. Use STOPBANG — score ≥3 = intermediate/high risk requiring further assessment or action.
High risk period: 1st–3rd post-operative night. Opioid analgesics suppress respiratory drive + REM rebound sleep (when OSA worst) = dangerous combination. Continuous SpO₂ monitoring mandatory for known OSA on opioids.
OSA is the most common cause of secondary/resistant hypertension. Nocturnal sympathetic surges → sustained HTN. CPAP reduces 24h BP by ~2–3 mmHg (greater in severe OSA + resistant HTN). Essential comorbidity to address.
OSA significantly increases AF risk and reduces cardioversion success rates. CPAP use is associated with reduced AF recurrence after cardioversion (most robust cardiovascular evidence for CPAP). All new AF patients should be screened for OSA.
OSA worsens heart failure through nocturnal hypoxia, negative intrathoracic pressure swings, and sympathetic activation. Cheyne-Stokes respiration (CSA pattern) in HF patients may require ASV (Adaptive Servo-Ventilation) — though ASV is contraindicated in HFrEF (EF <45%) based on SERVE-HF trial (increased mortality).
Gestational OSA is common and underdiagnosed. Weight gain, nasal congestion, and progesterone-mediated airway changes all increase risk during pregnancy.
CPAP safe in pregnancy — recommend for all pregnant women with confirmed moderate-severe OSA. Positional therapy (lateral sleep) also useful.
UAE and Saudi Arabia have high rates of bariatric surgery. Mandatory pre-operative sleep study is standard practice in GCC bariatric programmes — OSA is highly prevalent in morbidly obese patients and affects anaesthetic and post-operative care planning.
Legal obligation: In GCC countries, patients diagnosed with OSA have a legal obligation to inform the relevant driving authority. Untreated OSA causing excessive daytime sleepiness is a driving hazard — severely impairs reaction time and vigilance.
Must not drive while experiencing excessive daytime sleepiness. After commencing CPAP and demonstrating adequate adherence, driving licence can typically be maintained with regular review.
Severe consequences for untreated OSA and HGV driving. Commercial drivers (bus, truck, taxi) face licence revocation until compliant CPAP data is demonstrated. Very high-stakes screening priority.
Document that driving advice was given. Inform patient of legal duty to disclose. Facilitate rapid CPAP initiation for professional drivers. Record discussion in clinical notes — medicolegal protection.
| Severity | AHI Range | Key Clinical Feature |
|---|---|---|
| Mild | 5–15 events/h | Symptomatic snoring, mild sleepiness |
| Moderate | 15–30 events/h | Significant daytime impairment, HTN risk |
| Severe | >30 events/h | Profound somnolence, CV risk, metabolic syndrome |
| Normal | <5 events/h | No OSA diagnosis (note: some symptoms may still need evaluation) |
Indication: COPD exacerbation + pH 7.25–7.35 + PaCO₂ >6 kPa after 1h of optimal medical treatment
Click "Show Answer" to reveal each answer.
Answer all 8 questions. Score is calculated automatically. For educational use — not a clinical diagnostic tool.
Clinical screening tool for educational use only. Formal diagnosis requires overnight sleep study interpreted by a sleep physician.